SBRA250117C15000
- 1.80
- 0.000.00%
Sabra Health Care REIT Inc Newsroom
Truist Financial Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Announces Target Price $18
Mizuho Securities Downgrades Sabra Health Care REIT Inc(SBRA.US) to Hold Rating, Raises Target Price to $20
Sabra Health Care REIT Analyst Ratings
Mizuho Downgrades Sabra Health Care REIT to Neutral, Maintains Price Target to $20
BofA Securities Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Announces Target Price $21
Jefferies Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Raises Target Price to $21
Truist Financial Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating
Scotiabank Maintains Sabra Health Care REIT Inc(SBRA.US) With Hold Rating, Raises Target Price to $18
Scotiabank Maintains Sector Perform on Sabra Health Care REIT, Raises Price Target to $18
Sabra Healthcare REIT Coverage Assumed by Wells Fargo at Overweight Vs Previous Rating of Equal-Weight
Sabra Health Care REIT Analyst Ratings
Wells Fargo Upgrades 3, Downgrades 2 Healthcare REITs on Price to Earnings Growth and Yield
Wells Fargo Upgrades Sabra Health Care REIT Inc(SBRA.US) to Buy Rating, Raises Target Price to $20
Citigroup Upgrades Sabra Health Care REIT to Buy From Neutral, Price Target Is $20
Citi Upgrades Sabra Health Care REIT Inc(SBRA.US) to Buy Rating, Raises Target Price to $20
Truist Financial Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Maintains Target Price $18
Truist Financial Maintains Sabra Health Care REIT Inc(SBRA.US) With Buy Rating, Announces Target Price $18
Sabra Healthcare REIT Price Target Raised to $17.00/Share From $15.00 by Scotiabank
Sabra Health Care REIT Analyst Ratings
Scotiabank Maintains Sabra Health Care REIT Inc(SBRA.US) With Hold Rating, Raises Target Price to $17